Coronavirus Disease 2019 (COVID-19) in Children: Vulnerable or Spared? A Systematic Review

Hajra Saleem1, Jawaria Rahman2, Nida Aslam3

  • 1Family Medicine, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.

Cureus
|June 25, 2020
PubMed

Insights

Coronavirus disease 2019 (COVID-19) affects children similarly to adults, posing risks as carriers. Neonates and infants are particularly vulnerable, requiring careful handling and further research into diagnosis and management.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic has a global impact across all demographics.
  • Understanding the pediatric population's vulnerability to COVID-19 is crucial.

Purpose of the Study:

  • To assess the vulnerability of the pediatric population to COVID-19.
  • To review existing research on COVID-19 in children.

Main Methods:

  • Extensive literature search using PubMed database and Medical Subject Headings (MeSH).
  • Inclusion of studies from China with English translations.
  • Utilized World Health Organization (WHO) and Ontario Government data for statistical information.

Main Results:

  • COVID-19 affects the pediatric population, with varying reported symptom severity.
  • Some children experience milder symptoms, while others face life-threatening complications.
  • Children can transmit the virus, acting as carriers and endangering others.

Conclusions:

  • COVID-19 impacts children similarly to other age groups.
  • Neonates and infants can contract infections from family members, highlighting transmission risks within households.
  • Further research is needed on early diagnosis and management strategies for pediatric COVID-19 cases.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
161
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
121
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
182
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
159